ResMed Cash End of Year Trend

ResMed Inc -- USA Stock  

USD 88.79  0.11  0.12%

This module enables investors to look at ResMed various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 414.6 M, Cost of Revenue of 908.5 M or Earning Before Interest and Taxes EBIT of 530.3 M, but also many exotic indicators such as Long Term Debt to Equity of 0.6074, Calculated Tax Rate of 23.327 or PPandE Turnover of 5.5886. This module is a perfect complement to use when analyzing ResMed Valuation or Volatility. It can also complement various ResMed Technical models. Additionally take a look at analysis of ResMed Correlation with competitors.
Showing smoothed Cash End of Year of ResMed Inc with missing and latest data points interpolated.
Cash End of Year  10 Years Trend  
Increasing
Slightly volatile
 Cash End of Year 
      Timeline 

ResMed Cash End of Year Over Time

2016-12-31  731,434,000 
2017-12-31  731,434,000 
2018-12-31  860,510,588 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  660,149,507
Geometric Mean  618,003,245
Coefficient Of Variation  32.71
Mean Deviation  178,046,466
Median  731,434,000
Standard Deviation  215,936,272
Range  647,938,000
R Value  0.76
R Squared  0.59
Significance  0.002316
Slope  42,414,036

Currently Trending

VHT   
 PCX 
Purchased over 90 shares of
2 days ago ago
Traded for 162.09
VWO   
 PCX 
Purchased over 90 shares of
2 days ago ago
Traded for 48.23
MYSZ   
 NASDAQ 
Purchased over 100 shares of
2 days ago ago
Traded for 2.66